Participation of women in phase I oncology clinical trials

被引:0
|
作者
Vidal, L. [1 ]
Berg, R. [2 ]
Yang, Z. [3 ]
Moss, K. R. [4 ]
机构
[1] Syneos Hlth, Oncol, Barcelona, Spain
[2] Syneos Hlth, Oncol, Amsterdam, Netherlands
[3] Syneos Hlth, Biostat, Columbus, OH USA
[4] Syneos Hlth, Oncol, Kiryat Ono, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
495P
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Bayesian optimal interval design for phase I oncology clinical trials
    Fellman, Bryan M.
    Yuan, Ying
    STATA JOURNAL, 2015, 15 (01): : 110 - 120
  • [22] Presentation and subsequent publication rates of Phase I oncology clinical trials
    Camacho, LH
    Bacik, J
    Cheung, A
    Spriggs, DR
    CANCER, 2005, 104 (07) : 1497 - 1504
  • [23] Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials
    Fisher, Jill A.
    McManus, Lisa
    Wood, Megan M.
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Monahan, Torin
    Walker, Rebecca L.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2018, 13 (05) : 494 - 510
  • [24] Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity
    Awad, Eli
    Paladugu, Rajesh
    Jones, Nathaniel
    Pierce, Jennifer Young
    Scalici, Jennifer
    Hamilton, Chad A.
    Darcy, Kathleen M.
    Maxwell, G. Larry
    Rocconi, Rodney P.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (03) : 729 - 732
  • [25] Phase 1 clinical trials in oncology
    Miller, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23): : 2452 - 2452
  • [26] EMPOWERMENT AND PARTICIPATION OF WOMEN WITHIN CLINICAL TRIALS (EMPACT): A RESEARCH PROGRAM PROTOCOL IN GYNAECOLOGIC ONCOLOGY
    Nasser, Sara
    Bilir, Esra
    Kaufmann, Andreas
    Ullrich, Andreas
    Sehouli, Jalid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A217 - A217
  • [27] Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials
    Sharma, Manish R.
    Ratain, Mark J.
    CLINICAL CANCER RESEARCH, 2016, 22 (03) : 527 - 529
  • [28] EFFICACY PREDICTION IN PHASE I ONCOLOGY CLINICAL TRIALS USING DEEP LEARNING
    Aouchiche, B.
    Verlingue, L.
    Beinse, G.
    Massard, C.
    Borget, I
    VALUE IN HEALTH, 2019, 22 : S519 - S520
  • [29] Phase I clinical trials in oncology: A review of the old and a look at the new.
    Felinnan, Bryan M.
    Hess, Kenneth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] A tool for assessing adverse events in phase I/II oncology clinical trials
    Coombes, M.
    Mukherjee, S.
    Kowaleski, B.
    Levine, M.
    Cosby, J.
    Arnold, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)